Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.

Arteris stock closed at $9.45 on August 4, 2025, representing a 4.42% gain, but the real excitement began in premarket ...

Palantir’s role in U.S. public-private governance has never been clearer, and PLTR stock is moving in lockstep.

Caterpillar Inc.'s second-quarter 2025 results revealed a slight decline in sales and revenues compared to the previous year.